Clinical Director

Senior doctor, worked in public health services in the UK and Ireland for over 20 years. Honorary Senior Lecturer at The University of Oxford with past 10 years as Consultant Psychiatrist at Oxford University Hospital NHS Foundations Trust.

Therapy Lead

Former Head of Therapy Research and Training at COMPASS and Chief Clinical Officer at ieso Digital Health. Sarah has delivered over 30,000 hours of therapy and acted as Principal Investigator in trials.

Chief Investigator

20 years' experience in lab-based psychopharmacology and psychiatry. Honorary Clinical Senior Lecturer at King’s College London.​ Designed and coordinated numerous cannabinoid and ketamine trials with over 200 participants

Site Setup Director

14 years of experience leading clinical operations in private SMOs. Experience in leading cross-functional medical teams and leading implementations of new processes including enhanced protocol adherence, vendor set-up, patient recruitment, and licensing.

Senior Clinical Trials Manager

Over 12 years’ experience working with global CROs and top ten Pharma and Biotech as a Clinical Project Manager, including Icon, Syneos Health and Iqvia. Broad range of experience in the set-up and delivery of trials from phase I-IV in Oncology, CNS and imaging.​

Clinical Development and Senior Research Physician

Medical doctor and neuroscience graduate from Cambridge University and UCL. Co-founder of UCL Society for the Application of Psychedelics. Previously a researcher in clinical trials in the field of neuropsychiatry in the NHS.

Site Director

19 years of clinical and leadership experience in the NHS, CROs, and pharma, leading clinical and operational teams to optimise performance and processes. PhD in Health Science and recipient of the prestigious Rosemary Pope Fund Award for significant contributions to healthcare education and practice.

Senior Research Nurse

20 years’ clinical experience as a Registered Nurse, including 10 years in Clinical Research and Leadership in the NHS as Research Nurse and Senior Research Nurse in various fields: Cardiovascular, Critical Care, Oncology, Mental Health and Rare Diseases.

Research Nurse

14 years of experience as a nurse in the fields of Alzheimer’s and Dementia including 6 years of research experience in emergency departments.

Clinical Trials Assistant

MSc Psychological Therapies graduate from Queen Mary University. Previously worked as Head of Research at NHS Early Intervention in Psychosis Service, with clinical experience at Islington Mind.

Clinical Admin and Pharmacy Dispenser

BSc Forensic Science graduate with several years of experience as a scientist processing samples in biotechnology research companies including hVIVO.

Clinical Trial Pharmacist​

GPhC registered pharmacist with over 5 years' experience working within the NHS, specialising in Neurosciences and Clinical Trials. ​

Patient Recruitment Manager

BSc Experimental Psychology graduate from the University of Bristol,. Previously worked as an editor and manager for the Advanced Therapies Congress, specialising in Cell and Gene Therapies.

Research Nurse

Qualified as a nurse in 2015 at the University of La Sapienza in Rome. Experience working in acute hospital settings in Kent and across multiple sites in London. Spent a year in clinical research at Imperial College with Phase II and III trials.

Clinical Research Physician

Medical Doctor and graduate from UCL and Kings College London. 6 years of in-hospital experience, working mainly in Intensive care. Experienced research physician primarily in the neurodegeneration space, focusing on ASD, Alzheimer's disease and Parkinson's disease.

Clinical Trial Administrator

MSci in Pharmacology from King's College London, carried out research tackling antibiotic resistance and worked previously as an administrator in trial investigating Alzheimer's disease.

Clinical Trials Administrator

Psychology MScR graduate from the University of Edinburgh. Has worked in academic research for 4 years, with onsite work conducted in Poland, France, USA, and UK.

Junior Research Therapist

Trained in psychodynamic psychotherapy but has since transitioned to a more integrative approach, incorporating elements of relational, humanistic, and trauma-informed principles into her therapeutic practice.

Clinical Trials Administrator

BSc in Biomedicine from the University of Skovde, Sweden. Experienced in admin and data related work but passionate about clinical research to improve quality of life.

Chief Scientific Officer

Oxford PhD in CNS drug delivery. Started his career at the Beckley Foundation in 2015. Since then Henry has founded three companies in the psychedelics and cannabis sectors and advised clients on R&D strategies, IP generation and research operations. ​

Chief Executive Officer

Background in the biopharmaceutical sector including 18 months at IQVIA (formerly Quintilles-IMS, the world’s largest CRO) alongside experience across 5 of the global top 10 pharma companies.

Chief Financial Officer

FCCA qualified accountant with 10 years of restructuring, M&A strategy and commercial diligence for corporate clients at PwC’s Deals team in London and then as financial director at Hanway Associates.

Chief Commercial Officer

Commercial barrister turned drug policy reform advocate. Co-founded Hanway Associates, a strategic advisory firm working in the nascent European cannabis sector. Previously worked at Beckley Foundation and Volteface.

Marketing Manager

Researcher in health and innovation systems, consulting European & Developing Countries Clinical Trials Partnership and Foreign, Commonwealth & Development Office. Co-founded NeuroSight, a drug harm reduction consultancy.

Corporate Development Manager

Former start-up co-founder with a background in growth and operations in health tech and media. Philosophy, Politics and Economics graduate from the University of Oxford.

Financial Manager

CIMA Chartered Global Management Accountant. Over the 10+ years of service, served in senior financial roles in multinational and international corporations, driving strategic financial growth and operational excellence.

Business Development Executive

9 years of global drug development experience with a background in project delivery of Phase I-III trials across a range of therapeutic areas and more recently, a range of commercial roles at small and large CROs in Australia and the UK.

Head of Quality

15 years of clinical research experience across public and commercial sectors, with a background in operational delivery before moving into quality assurance and regulatory affairs. Worked closely with regulators including the MHRA and HRA.

Quality Assurance Manager

Worked in academia and industry for a number of years as both a Quality Manager and bench scientist collecting and processing samples for cancer and neurological research and Clinical Trials.​

Quality Assurance Manager

8 years experience in clinical trials with over 4 years in participant recruitment and 3 years as a Quality Research Associate at one of Europe’s largest phase 1 units.

20 years experience in pharmacology & psychiatry. Hon. Sen. Lecturer at King’s College London. Designed numerous trials with >200 participants.​

Consultant Psychiatrist and Hon. Sen. Lecturer at Uni. of Glasgow, with 17 years experience in mental health. Led NHS and commercial trials as Sen. Researcher.

Principal, Chief, and National lead to 120 trials at leading CROs and hospitals in the last decade. Also medical monitoring expert​.

Affil. Asst. Professor at University of Cambridge. Also Medical Leader in Psychosis at Cambridgeshire & Peterborough NHS FT​.

Expertise in clinical drug development and phase I – IV studies as clinical research physician in Re:Cognition Health, Quotient Sciences and Protas.

20 years as Consultant Psychiatrist with past 10 years at ​Oxford University Hospital NHS FT. Also Hon. Sen. Lecturer at University of Oxford​.

22 years at GSK, most recently as Therapeutic Director for CNS diseases. Co-founder of three drug discovery companies and board member of several others.

Clinical Director and Deputy Head of the Centre for Psychedelic Research at Imperial College London. Consultant Psychiatrist at CNWL Mental Health NHS Foundation Trust.

Associate Professor at University of Copenhagen and Copenhagen University Hospital. Honorary Clinical Research Fellow in Centre for Psychedelic Research at Imperial.

Associate Professor at Maastricht University, at the Faculty of Psychology and Neuroscience. PhD focused on memory and risk-taking during MDMA intoxication.

UK&I Head of Start-up Ventures and Open Innovation at Accenture. Over 10 years experience working across a range of digital strategy, analytics and technology transformation projects.

CEO and Founder of braincare company, Heights Braincare. Host of the UK's #1 business podcast, Secret Leaders.